Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 6, 2002, Pages 929-935

  Fowler, Stephen J ^a   Currie, Graeme P ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Asthma therapy; Beclomethasone; Bronchial hyperreactivity; Fluticasone propionate; Salmeterol

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; METHACHOLINE; NORFLURANE; OSTEOCALCIN; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE MARKER; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; DRY POWDER; EMOTION; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; POWDER INHALER; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036286458     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.123869     Document Type: Article

References (34)

1. The British guidelines on asthma management: 1995 review and position statement
2. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
3. Effect of inhaled formoterol and budesonide on exacerbations of asthma
4. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations
5. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
6. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
7. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate
8. Improved delivery of inhaled steroids to the large and small airways
9. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials
10. Determining a minimal important change in a disease-specific Quality of Life Questionnaire
11. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract
12. Standardization of spirometry - 1987 update
13. Measurement of airway responsiveness to methacholine: Relative importance of the precision of drug delivery and the method of assessing response
14. Aerosol particle generation from dry powder inhalers: Can they equal pressurized metered dose inhalers?
15. Baseline airway hyperresponsiveness and its reversible component: Role of airway inflammation and airway calibre
16. The long-term effect of nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects
17. Effect of long-term treatment with salmeterol on asthma control: A double blind, randomised crossover study
18. A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine
19. Bronchodilator subsensitivity to albuterol after twice daily salmeterol in asthmatic patients
20. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol
21. Alveolar tissue inflammation in asthma
22. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography
23. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
24. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
25. Decreased bronchodilating effect of albuterol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta(2) agonists
26. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
27. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma
28. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults
29. The long-acting beta2-agonist salmeterol xinafoate: Effects on airway inflammation in asthma
30. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics
31. The effect of salmeterol on markers of airway inflammation following segmental allergen challenge
32. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: A randomized controlled trial
33. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
34. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism